Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AZD-8871 can present a novel treatment approach to chronic obstructive pulmonary disease [COPD] and potentially also asthma (in combination with an inhaled corticosteroid [ICS]).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | AZD-8871 can present a novel treatment approach to chronic obstructive pulmonary disease [COPD] and potentially also asthma (in combination with an inhaled corticosteroid [ICS]). |
Synonyms | AZD8871, LAS-191351, AZD 8871, LAS191351, AZD-8871, LAS 191351 |
Molecular Weight | 742.91 |
Formula | C38H42N6O6S2 |
CAS No. | 1435519-06-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Navafenterol 1435519-06-4 AZD8871 LAS-191351 AZD 8871 LAS191351 AZD-8871 LAS 191351 inhibitor inhibit